AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · IEX Real-Time Price · USD
7.88
+0.16 (2.07%)
Jul 2, 2024, 4:00 PM EDT - Market closed

AVITA Medical Balance Sheet

Millions AUD. Fiscal year is Jan - Dec.
Year
20232022202120202019 2018 - 2017
Cash & Equivalents
22.1218.1655.7173.8420.37
Upgrade
Short-Term Investments
66.9461.1829.6500
Upgrade
Cash & Cash Equivalents
89.0679.3485.3673.8420.37
Upgrade
Cash Growth
12.24%-7.05%15.60%262.42%93.55%
Upgrade
Receivables
7.694.413.432.431.79
Upgrade
Inventory
5.62.132.131.130.74
Upgrade
Other Current Assets
1.661.581.210.991.22
Upgrade
Total Current Assets
104.0187.4692.1378.3924.13
Upgrade
Property, Plant & Equipment
4.322.052.813.711.31
Upgrade
Long-Term Investments
06.9319.6900
Upgrade
Goodwill and Intangibles
0.490.470.440.360.23
Upgrade
Other Long-Term Assets
2.831.360.9400.13
Upgrade
Total Long-Term Assets
7.6310.8123.884.081.66
Upgrade
Total Assets
111.6498.26116.0282.4625.78
Upgrade
Accounts Payable
3.7932.714.331.92
Upgrade
Deferred Revenue
0.360.70.950.440.43
Upgrade
Other Current Liabilities
9.056.995.492.942.14
Upgrade
Total Current Liabilities
13.210.699.157.714.48
Upgrade
Long-Term Debt
41.510.310.921.920
Upgrade
Other Long-Term Liabilities
7.181.971.330.440.47
Upgrade
Total Long-Term Liabilities
48.692.272.252.350.47
Upgrade
Total Liabilities
61.8912.9711.3910.064.95
Upgrade
Total Debt
41.510.310.921.920
Upgrade
Debt Growth
13466.67%-66.67%-52.11%--
Upgrade
Retained Earnings
-297.97-262.59-235.92-194.91-152.83
Upgrade
Comprehensive Income
-1.897.638.068.158.18
Upgrade
Shareholders' Equity
49.0684.74104.6272.420.83
Upgrade
Net Cash / Debt
47.5479.0484.4471.9220.37
Upgrade
Net Cash / Debt Growth
-39.85%-6.40%17.41%253.01%95.32%
Upgrade
Net Cash Per Share
1.883.163.393.541.27
Upgrade
Working Capital
90.8176.7782.9970.6819.64
Upgrade
Book Value Per Share
1.943.394.203.571.30
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).